Prospective use of intramuscular triamcinolone acetonide in pseudogout

Douglas W. Roane, Mark D. Harris, Matthew T. Carpenter, David R. Finger, Mark J. Jarek, Jeff A. Alloway, Alan R. Erickson, William E. Venanzi, Timothy J. Drehmer

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


Objective. To prospectively assess the efficacy of intramuscular (im) triamcinolone acetonide in the treatment of pseudogout. Methods. Fourteen patients with crystal proven pseudogout presenting with an acute attack within 5 days of onset were treated with intramuscular triamcinolone acetonide 60 mg and followed for 30 days. Patients with inadequate response were eligible for a 2nd triamcinolone acetonide injection on Day 1-2. Results. Twelve patients had contraindication to nonsteroidal antiinflammatory agents (NSAID). Acute arthritis was monoarticular in 10 patients, and involved 2 or more joints in 4 patients. All patients had good clinical response to triamcinolone acetonide based on restoration of near baseline joint range of motion and joint circumference, and at least 50% improvement in patient and physician global assessment. Major clinical improvement occurred by Day 1-2 (2 patients), Day 3-4 (11 patients), and Day 10-14 (one patient). Six patients required a 2nd triamcinolone acetonide injection on Day 1-2. Toxicities were not observed. Conclusion. im triamcinolone acetonide appears to be safe, well tolerated, and effective in the treatment of pseudogout. It may be a reasonable alternative therapy when NSAID are contraindicated, and for polyarticular attacks where intraarticular corticosteroids are impractical.

Original languageEnglish (US)
Pages (from-to)1168-1170
Number of pages3
JournalJournal of Rheumatology
Issue number6
StatePublished - Jun 1997
Externally publishedYes


  • Calcium pyrophosphate dihydrate deposition disease
  • Corticosteroids
  • Pseudogout
  • Triamcinolone acetonide

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Prospective use of intramuscular triamcinolone acetonide in pseudogout'. Together they form a unique fingerprint.

Cite this